BCI Affects and Survivorship

Susan K Boolbol, MD
Stephen C. Malamud, MD
Dr Susan K. Boolbol talks about the importance of objective evidence provided by the Breast Cancer IndexSM (BCI) in treatment decision making.
Related Articles
Navigating Lung Cancer Patients at Fox Chase Cancer Center
August 2018 Vol 9, No 8
An Interview with Maria Kadlec, BSN, RN; Caryn M. Vadseth, BSN, RN, OCN; and Mary Pat Winterhalter, MS, BSN, RN, NE-BC
How Molecular Biomarkers Have Impacted Cancer Treatment
Geoff Oxnard, MD, Lauren Ritterhouse, MD, PhD
|
Video Library
Drs Geoffrey Oxnard and Lauren Ritterhouse discuss the challenges and opportunities of precision medicine and molecular biomarkers in their clinical practice from an oncologist’s and a pathologist’s perspective.
Optimizing Communication Between Oncologists and Pathologists on Cancer Biomarker Testing
Geoff Oxnard, MD, Lauren Ritterhouse, MD, PhD
|
Video Library
Drs Geoffrey Oxnard and Lauren Ritterhouse discuss the best ways oncologists and pathologists can communicate about molecular biomarker testing for individual patients as well as on strategies for incorporating new biomarkers into testing panels.
Last modified: June 10, 2018

Subscribe to the Journal of Oncology Navigation & Survivorship®

To sign up for our print publication or e-newsletter, please enter your contact information below.

  • First Name *
    Last Name *
     
    Country
  • Please enter your mailing address.

    Address
     
    Address Line 2
    City
     
    State
    Zip Code